{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T17:35:34Z","timestamp":1755797734822,"version":"3.37.3"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["Intramural Research Program"],"award-info":[{"award-number":["Intramural Research Program"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroimmune Pharmacol"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11481-019-09856-z","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T06:02:19Z","timestamp":1559800939000},"page":"565-577","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Cas9 Ribonucleoprotein Complex Delivery: Methods and Applications for Neuroinflammation"],"prefix":"10.1007","volume":"14","author":[{"given":"Lee A.","family":"Campbell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher T.","family":"Richie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishad S.","family":"Maggirwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4036-1383","authenticated-orcid":false,"given":"Brandon K.","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"9856_CR1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s42003-018-0054-2","volume":"1","author":"EJ Aird","year":"2018","unstructured":"Aird EJ, Lovendahl KN, St Martin A, Harris RS, Gordon WR (2018) Increasing Cas9-mediated homology-directed repair efficiency through covalent tethering of DNA repair template. Commun Biol 1:54","journal-title":"Commun Biol"},{"key":"9856_CR2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.nano.2013.09.011","volume":"10","author":"JP Almeida","year":"2014","unstructured":"Almeida JP, Figueroa ER, Drezek RA (2014) Gold nanoparticle mediated cancer immunotherapy. Nanomedicine 10:503\u2013514","journal-title":"Nanomedicine"},{"key":"9856_CR3","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.celrep.2017.06.064","volume":"20","author":"RO Bak","year":"2017","unstructured":"Bak RO, Porteus MH (2017) CRISPR-mediated integration of large gene cassettes using AAV donor vectors. Cell Rep 20:750\u2013756","journal-title":"Cell Rep"},{"issue":"Suppl 2","key":"9856_CR4","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3949\/ccjm.78.s2.03","volume":"78","author":"JR Berger","year":"2011","unstructured":"Berger JR (2011) The clinical features of PML. Cleve Clin J Med 78(Suppl 2):S8\u2013S12","journal-title":"Cleve Clin J Med"},{"key":"9856_CR5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.molcel.2017.08.008","volume":"67","author":"P Billon","year":"2017","unstructured":"Billon P, Bryant EE, Joseph SA, Nambiar TS, Hayward SB, Rothstein R, Ciccia A (2017) CRISPR-Mediated Base editing enables efficient disruption of eukaryotic genes through induction of STOP codons. Mol Cell 67:1068\u20131079.e4","journal-title":"Mol Cell"},{"key":"9856_CR6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ymthe.2018.10.002","volume":"27","author":"LA Campbell","year":"2019","unstructured":"Campbell LA, Coke LM, Richie CT, Fortuno LV, Park AY, Harvey BK (2019) Gesicle-mediated delivery of CRISPR\/Cas9 ribonucleoprotein complex for inactivating the HIV provirus. Mol Ther 27:151\u2013163","journal-title":"Mol Ther"},{"key":"9856_CR7","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/cr.2013.45","volume":"23","author":"N Chang","year":"2013","unstructured":"Chang N, Sun C, Gao L, Zhu D, Xu X, Zhu X, Xiong JW, Xi JJ (2013) Genome editing with RNA-guided Cas9 nuclease in zebrafish embryos. Cell Res 23:465\u2013472","journal-title":"Cell Res"},{"key":"9856_CR8","doi-asserted-by":"crossref","first-page":"14457","DOI":"10.1074\/jbc.M116.733154","volume":"291","author":"S Chen","year":"2016","unstructured":"Chen S, Lee B, Lee AY, Modzelewski AJ, He L (2016) Highly efficient mouse genome editing by CRISPR ribonucleoprotein electroporation of zygotes. J Biol Chem 291:14457\u201314467","journal-title":"J Biol Chem"},{"key":"9856_CR9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/glia.23081","volume":"65","author":"NC Chen","year":"2017","unstructured":"Chen NC, Partridge AT, Sell C, Torres C, Mart\u00edn-Garc\u00eda J (2017) Fate of microglia during HIV-1 infection: from activation to senescence? Glia 65:431\u2013446","journal-title":"Glia"},{"key":"9856_CR10","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nmeth.3993","volume":"13","author":"WL Chew","year":"2016","unstructured":"Chew WL, Tabebordbar M, Cheng JK, Mali P, Wu EY, Ng AH, Zhu K, Wagers AJ, Church GM (2016) A multifunctional AAV-CRISPR-Cas9 and its host response. Nat Methods 13:868\u2013874","journal-title":"Nat Methods"},{"key":"9856_CR11","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1534\/genetics.113.155853","volume":"195","author":"SW Cho","year":"2013","unstructured":"Cho SW, Lee J, Carroll D, Kim JS (2013) Heritable gene knockout in Caenorhabditis elegans by direct injection of Cas9-sgRNA ribonucleoproteins. Genetics 195:1177\u20131180","journal-title":"Genetics"},{"key":"9856_CR12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1231143","volume":"339","author":"L Cong","year":"2013","unstructured":"Cong L, Ran FA, Cox D, Lin S, Barretto R, Habib N, Hsu PD, Wu X, Jiang W, Marraffini LA, Zhang F (2013) Multiplex genome engineering using CRISPR\/Cas systems. Science 339:819\u2013823","journal-title":"Science"},{"key":"9856_CR13","doi-asserted-by":"crossref","first-page":"9584","DOI":"10.1093\/nar\/gkt714","volume":"41","author":"TJ Cradick","year":"2013","unstructured":"Cradick TJ, Fine EJ, Antico CJ, Bao G (2013) CRISPR\/Cas9 systems targeting \u03b2-globin and CCR5 genes have substantial off-target activity. Nucleic Acids Res 41:9584\u20139592","journal-title":"Nucleic Acids Res"},{"key":"9856_CR14","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1038\/s41467-018-05843-9","volume":"9","author":"JM Crudele","year":"2018","unstructured":"Crudele JM, Chamberlain JS (2018) Cas9 immunity creates challenges for CRISPR gene editing therapies. Nat Commun 9:3497","journal-title":"Nat Commun"},{"key":"9856_CR15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fnins.2018.00075","volume":"12","author":"M Dabrowska","year":"2018","unstructured":"Dabrowska M, Juzwa W, Krzyzosiak WJ, Olejniczak M (2018) Precise excision of the CAG tract from the huntingtin gene by Cas9 Nickases. Front Neurosci 12:75","journal-title":"Front Neurosci"},{"key":"9856_CR16","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.15585\/mmwr.mm6736a2","volume":"67","author":"J Dahlhamer","year":"2018","unstructured":"Dahlhamer J, Lucas J, Zelaya C, Nahin R, Mackey S, DeBar L, Kerns R, Von Korff M, Porter L, Helmick C (2018) Prevalence of chronic pain and high-impact chronic pain among adults - United States, 2016. MMWR Morb Mortal Wkly Rep 67:1001\u20131006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"9856_CR17","doi-asserted-by":"crossref","first-page":"e0195558","DOI":"10.1371\/journal.pone.0195558","volume":"13","author":"T Del'Guidice","year":"2018","unstructured":"Del'Guidice T, Lepetit-Stoffaes JP, Bordeleau LJ, Roberge J, Th\u00e9berge V, Lauvaux C, Barbeau X, Trottier J, Dave V, Roy DC, Gaillet B, Garnier A, Guay D (2018) Membrane permeabilizing amphiphilic peptide delivers recombinant transcription factor and CRISPR-Cas9\/Cpf1 ribonucleoproteins in hard-to-modify cells. PLoS One 13:e0195558","journal-title":"PLoS One"},{"key":"9856_CR18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12974-019-1453-0","volume":"16","author":"DA Dionisio-Santos","year":"2019","unstructured":"Dionisio-Santos DA, Olschowka JA, O'Banion MK (2019) Exploiting microglial and peripheral immune cell crosstalk to treat Alzheimer's disease. J Neuroinflammation 16:74","journal-title":"J Neuroinflammation"},{"key":"9856_CR19","doi-asserted-by":"crossref","first-page":"1258096","DOI":"10.1126\/science.1258096","volume":"346","author":"JA Doudna","year":"2014","unstructured":"Doudna JA, Charpentier E (2014) Genome editing. The new frontier of genome engineering with CRISPR-Cas9. Science 346:1258096","journal-title":"Science"},{"key":"9856_CR20","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, Sander JD (2013) High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol 31:822\u2013826","journal-title":"Nat Biotechnol"},{"key":"9856_CR21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","volume":"551","author":"NM Gaudelli","year":"2017","unstructured":"Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR (2017) Programmable base editing of a\u2022T to G\u2022C in genomic DNA without DNA cleavage. Nature 551:464\u2013471","journal-title":"Nature"},{"key":"9856_CR22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-3-319-66095-0_11","volume":"1030","author":"M Gestin","year":"2017","unstructured":"Gestin M, Dowaidar M, Langel \u00dc (2017) Uptake mechanism of cell-penetrating peptides. Adv Exp Med Biol 1030:255\u2013264","journal-title":"Adv Exp Med Biol"},{"key":"9856_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jneuroim.2005.01.022","volume":"163","author":"A Ghorpade","year":"2005","unstructured":"Ghorpade A, Persidsky Y, Swindells S, Borgmann K, Persidsky R, Holter S, Cotter R, Gendelman HE (2005) Neuroinflammatory responses from microglia recovered from HIV-1-infected and seronegative subjects. J Neuroimmunol 163:145\u2013156","journal-title":"J Neuroimmunol"},{"key":"9856_CR24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.omtn.2018.03.007","volume":"11","author":"B Gy\u00f6rgy","year":"2018","unstructured":"Gy\u00f6rgy B, L\u00f6\u00f6v C, Zaborowski MP, Takeda S, Kleinstiver BP, Commins C, Kastanenka K, Mu D, Volak A, Giedraitis V, Lannfelt L, Maguire CA, Joung JK, Hyman BT, Breakefield XO, Ingelsson M (2018) CRISPR\/Cas9 mediated disruption of the Swedish APP allele as a therapeutic approach for early-onset Alzheimer's disease. Mol Ther Nucleic Acids 11:429\u2013440","journal-title":"Mol Ther Nucleic Acids"},{"key":"9856_CR25","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.97.16.8856","volume":"97","author":"RE Hancock","year":"2000","unstructured":"Hancock RE, Scott MG (2000) The role of antimicrobial peptides in animal defenses. Proc Natl Acad Sci U S A 97:8856\u20138861","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9856_CR26","first-page":"3","volume":"17","author":"RK Heaton","year":"2011","unstructured":"Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neuro-Oncol 17:3\u201316","journal-title":"J Neuro-Oncol"},{"key":"9856_CR27","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.cell.2016.01.039","volume":"164","author":"H Hirano","year":"2016","unstructured":"Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, Nishimasu H, Nureki O (2016) Structure and engineering of Francisella novicida Cas9. Cell 164:950\u2013961","journal-title":"Cell"},{"key":"9856_CR28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, Li Y, Fine EJ, Wu X, Shalem O, Cradick TJ, Marraffini LA, Bao G, Zhang F (2013) DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol 31:827\u2013832","journal-title":"Nat Biotechnol"},{"key":"9856_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ymeth.2017.03.021","volume":"121-122","author":"AM Jacobi","year":"2017","unstructured":"Jacobi AM, Rettig GR, Turk R, Collingwood MA, Zeiner SA, Quadros RM, Harms DW, Bonthuis PJ, Gregg C, Ohtsuka M, Gurumurthy CB, Behlke MA (2017) Simplified CRISPR tools for efficient genome editing and streamlined protocols for their delivery into mammalian cells and mouse zygotes. Methods 121-122:16\u201328","journal-title":"Methods"},{"key":"9856_CR30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2017.08.039","volume":"658","author":"AM Jeffries","year":"2017","unstructured":"Jeffries AM, Marriott I (2017) Human microglia and astrocytes express cGAS-STING viral sensing components. Neurosci Lett 658:53\u201356","journal-title":"Neurosci Lett"},{"key":"9856_CR31","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nrd4334","volume":"13","author":"RR Ji","year":"2014","unstructured":"Ji RR, Xu ZZ, Gao YJ (2014) Emerging targets in neuroinflammation-driven chronic pain. Nat Rev Drug Discov 13:533\u2013548","journal-title":"Nat Rev Drug Discov"},{"key":"9856_CR32","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.1225829","volume":"337","author":"M Jinek","year":"2012","unstructured":"Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E (2012) A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337:816\u2013821","journal-title":"Science"},{"key":"9856_CR33","doi-asserted-by":"crossref","first-page":"e00471","DOI":"10.7554\/eLife.00471","volume":"2","author":"M Jinek","year":"2013","unstructured":"Jinek M, East A, Cheng A, Lin S, Ma E, Doudna J (2013) RNA-programmed genome editing in human cells. Elife 2:e00471","journal-title":"Elife"},{"key":"9856_CR34","doi-asserted-by":"crossref","first-page":"e1001450","DOI":"10.1371\/journal.pbio.1001450","volume":"10","author":"H Kalra","year":"2012","unstructured":"Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P, Bond VC, Borr\u00e0s FE, Breakefield X, Budnik V, Buzas E, Camussi G, Clayton A, Cocucci E, Falcon-Perez JM, Gabrielsson S, Gho YS, Gupta D, Harsha HC, Hendrix A, Hill AF, Inal JM, Jenster G, Kr\u00e4mer-Albers EM, Lim SK, Llorente A, L\u00f6tvall J, Marcilla A, Mincheva-Nilsson L, Nazarenko I, Nieuwland R, Nolte-'t Hoen EN, Pandey A, Patel T, Piper MG, Pluchino S, Prasad TS, Rajendran L, Raposo G, Record M, Reid GE, S\u00e1nchez-Madrid F, Schiffelers RM, Siljander P, Stensballe A, Stoorvogel W, Taylor D, Thery C, Valadi H, van Balkom BW, V\u00e1zquez J, Vidal M, Wauben MH, Y\u00e1\u00f1ez-M\u00f3 M, Zoeller M, Mathivanan S (2012) Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10:e1001450","journal-title":"PLoS Biol"},{"key":"9856_CR35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/nrg3686","volume":"15","author":"H Kim","year":"2014","unstructured":"Kim H, Kim JS (2014) A guide to genome engineering with programmable nucleases. Nat Rev Genet 15:321\u2013334","journal-title":"Nat Rev Genet"},{"key":"9856_CR36","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1101\/gr.171322.113","volume":"24","author":"S Kim","year":"2014","unstructured":"Kim S, Kim D, Cho SW, Kim J, Kim JS (2014) Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res 24:1012\u20131019","journal-title":"Genome Res"},{"key":"9856_CR37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/nbt.3816","volume":"35","author":"K Kim","year":"2017","unstructured":"Kim K, Ryu SM, Kim ST, Baek G, Kim D, Lim K, Chung E, Kim S, Kim JS (2017) Highly efficient RNA-guided base editing in mouse embryos. Nat Biotechnol 35:435\u2013437","journal-title":"Nat Biotechnol"},{"key":"9856_CR38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aao4774","volume":"3","author":"AC Komor","year":"2017","unstructured":"Komor AC, Zhao KT, Packer MS, Gaudelli NM, Waterbury AL, Koblan LW, Kim YB, Badran AH, Liu DR (2017) Improved base excision repair inhibition and bacteriophage Mu gam protein yields C:G-to-T:A base editors with higher efficiency and product purity. Sci Adv 3:eaao4774","journal-title":"Sci Adv"},{"key":"9856_CR39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0186112","volume":"12","author":"H Kumagai","year":"2017","unstructured":"Kumagai H, Nakanishi T, Matsuura T, Kato Y, Watanabe H (2017) CRISPR\/Cas-mediated knock-in via non-homologous end-joining in the crustacean Daphnia magna. PLoS One 12:e0186112","journal-title":"PLoS One"},{"key":"9856_CR40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nmeth.4327","volume":"14","author":"C Kuscu","year":"2017","unstructured":"Kuscu C, Parlak M, Tufan T, Yang J, Szlachta K, Wei X, Mammadov R, Adli M (2017) CRISPR-STOP: gene silencing through base-editing-induced nonsense mutations. Nat Methods 14:710\u2013712","journal-title":"Nat Methods"},{"key":"9856_CR41","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.talanta.2017.09.012","volume":"177","author":"M Laura Soriano","year":"2018","unstructured":"Laura Soriano M, Zougagh M, Valc\u00e1rcel M, R\u00edos \u00c1 (2018) Analytical nanoscience and nanotechnology: where we are and where we are heading. Talanta 177:104\u2013121","journal-title":"Talanta"},{"key":"9856_CR42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","volume":"1","author":"K Lee","year":"2017","unstructured":"Lee K, Conboy M, Park HM, Jiang F, Kim HJ, Dewitt MA, Mackley VA, Chang K, Rao A, Skinner C, Shobha T, Mehdipour M, Liu H, Huang WC, Lan F, Bray NL, Li S, Corn JE, Kataoka K, Doudna JA, Conboy I, Murthy N (2017) Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA. Nat Biomed Eng 1:889\u2013901","journal-title":"Nat Biomed Eng"},{"key":"9856_CR43","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/archneurol.2007.31","volume":"65","author":"S Letendre","year":"2008","unstructured":"Letendre S, Marquie-Beck J, Capparelli E, Best B, Clifford D, Collier AC, Gelman BB, JC MA, JA MC, Morgello S, Simpson D, Grant I, Ellis RJ, Group C (2008) Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 65:65\u201370","journal-title":"Arch Neurol"},{"key":"9856_CR44","doi-asserted-by":"crossref","first-page":"e04766","DOI":"10.7554\/eLife.04766","volume":"3","author":"S Lin","year":"2014","unstructured":"Lin S, Staahl BT, Alla RK, Doudna JA (2014) Enhanced homology-directed human genome engineering by controlled timing of CRISPR\/Cas9 delivery. Elife 3:e04766","journal-title":"Elife"},{"key":"9856_CR45","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1038\/nprot.2015.117","volume":"10","author":"J Liu","year":"2015","unstructured":"Liu J, Gaj T, Yang Y, Wang N, Shui S, Kim S, Kanchiswamy CN, Kim JS, Barbas CF (2015) Efficient delivery of nuclease proteins for genome editing in human stem cells and primary cells. Nat Protoc 10:1842\u20131859","journal-title":"Nat Protoc"},{"key":"9856_CR46","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1126\/science.1232033","volume":"339","author":"P Mali","year":"2013","unstructured":"Mali P, Yang L, Esvelt KM, Aach J, Guell M, DiCarlo JE, Norville JE, Church GM (2013) RNA-guided human genome engineering via Cas9. Science 339:823\u2013826","journal-title":"Science"},{"key":"9856_CR47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41467-018-07845-z","volume":"10","author":"PE Mangeot","year":"2019","unstructured":"Mangeot PE, Risson V, Fusil F, Marnef A, Laurent E, Blin J, Mournetas V, Massourid\u00e8s E, Sohier TJM, Corbin A, Aub\u00e9 F, Teixeira M, Pinset C, Schaeffer L, Legube G, Cosset FL, Verhoeyen E, Ohlmann T, Ricci EP (2019) Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins. Nat Commun 10:45","journal-title":"Nat Commun"},{"key":"9856_CR48","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.isci.2018.10.030","volume":"9","author":"N Mizuno","year":"2018","unstructured":"Mizuno N, Mizutani E, Sato H, Kasai M, Ogawa A, Suchy F, Yamaguchi T, Nakauchi H (2018) Intra-embryo gene cassette Knockin by CRISPR\/Cas9-mediated genome editing with adeno-associated viral vector. iScience 9:286\u2013297","journal-title":"iScience"},{"key":"9856_CR49","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.omtn.2018.05.010","volume":"12","author":"C Montagna","year":"2018","unstructured":"Montagna C, Petris G, Casini A, Maule G, Franceschini GM, Zanella I, Conti L, Arnoldi F, Burrone OR, Zentilin L, Zacchigna S, Giacca M, Cereseto A (2018) VSV-G-enveloped vesicles for traceless delivery of CRISPR-Cas9. Mol Ther Nucleic Acids 12:453\u2013462","journal-title":"Mol Ther Nucleic Acids"},{"key":"9856_CR50","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1021\/acsnano.6b07600","volume":"11","author":"R Mout","year":"2017","unstructured":"Mout R, Ray M, Yesilbag Tonga G, Lee YW, Tay T, Sasaki K, Rotello VM (2017) Direct cytosolic delivery of CRISPR\/Cas9-ribonucleoprotein for efficient gene editing. ACS Nano 11:2452\u20132458","journal-title":"ACS Nano"},{"key":"9856_CR51","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/j.pain.0000000000001002","volume":"158","author":"A Moutal","year":"2017","unstructured":"Moutal A, Yang X, Li W, Gilbraith KB, Luo S, Cai S, Fran\u00e7ois-Moutal L, Chew LA, Yeon SK, Bellampalli SS, Qu C, Xie JY, Ibrahim MM, Khanna M, Park KD, Porreca F, Khanna R (2017) CRISPR\/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide. Pain 158:2301\u20132319","journal-title":"Pain"},{"key":"9856_CR52","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s40473-018-0156-7","volume":"5","author":"F Munoz","year":"2018","unstructured":"Munoz F, Aurup C, Konofagou EE, Ferrera VP (2018) Modulation of brain function and behavior by focused ultrasound. Curr Behav Neurosci Rep 5:153\u2013164","journal-title":"Curr Behav Neurosci Rep"},{"key":"9856_CR53","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1038\/mtna.2016.49","volume":"5","author":"G Murlidharan","year":"2016","unstructured":"Murlidharan G, Sakamoto K, Rao L, Corriher T, Wang D, Gao G, Sullivan P, Asokan A (2016) CNS-restricted transduction and CRISPR\/Cas9-mediated gene deletion with an engineered AAV vector. Mol Ther Nucleic Acids 5:e338","journal-title":"Mol Ther Nucleic Acids"},{"key":"9856_CR54","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1242\/bio.019349","volume":"5","author":"Y Nakagawa","year":"2016","unstructured":"Nakagawa Y, Sakuma T, Nishimichi N, Yokosaki Y, Yanaka N, Takeo T, Nakagata N, Yamamoto T (2016) Ultra-superovulation for the CRISPR-Cas9-mediated production of gene-knockout, single-amino-acid-substituted, and floxed mice. Biol Open 5:1142\u20131148","journal-title":"Biol Open"},{"key":"9856_CR55","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.neuron.2017.10.004","volume":"96","author":"J Nishiyama","year":"2017","unstructured":"Nishiyama J, Mikuni T, Yasuda R (2017) Virus-mediated genome editing via homology-directed repair in mitotic and Postmitotic cells in mammalian brain. Neuron 96:755\u2013768.e5","journal-title":"Neuron"},{"key":"9856_CR56","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1534\/genetics.115.179382","volume":"201","author":"A Paix","year":"2015","unstructured":"Paix A, Folkmann A, Rasoloson D, Seydoux G (2015) High efficiency, homology-directed genome editing in Caenorhabditis elegans using CRISPR-Cas9 ribonucleoprotein complexes. Genetics 201:47\u201354","journal-title":"Genetics"},{"key":"9856_CR57","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymeth.2017.03.023","volume":"121-122","author":"A Paix","year":"2017","unstructured":"Paix A, Folkmann A, Seydoux G (2017) Precision genome editing using CRISPR-Cas9 and linear repair templates in C. elegans. Methods 121-122:86\u201393","journal-title":"Methods"},{"key":"9856_CR58","first-page":"823","volume":"40","author":"DS Park","year":"2017","unstructured":"Park DS, Yoon M, Kweon J, Jang AH, Kim Y, Choi SC (2017) Targeted Base editing via RNA-guided cytidine deaminases in Xenopus laevis embryos. Mol Cell 40:823\u2013827","journal-title":"Mol Cell"},{"key":"9856_CR59","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1534\/genetics.115.176594","volume":"200","author":"W Qin","year":"2015","unstructured":"Qin W, Dion SL, Kutny PM, Zhang Y, Cheng AW, Jillette NL, Malhotra A, Geurts AM, Chen YG, Wang H (2015) Efficient CRISPR\/Cas9-mediated genome editing in mice by zygote electroporation of nuclease. Genetics 200:423\u2013430","journal-title":"Genetics"},{"key":"9856_CR60","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/abbs\/gmx064","volume":"49","author":"S Qin","year":"2017","unstructured":"Qin S, Jiang F, Zhou Y, Zhou G, Ye P, Ji Y (2017) Local knockdown of Nav1.6 relieves pain behaviors induced by BmK I. Acta Biochim Biophys Sin Shanghai 49:713\u2013721","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"key":"9856_CR61","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","volume":"154","author":"FA Ran","year":"2013","unstructured":"Ran FA, Hsu PD, Lin CY, Gootenberg JS, Konermann S, Trevino AE, Scott DA, Inoue A, Matoba S, Zhang Y, Zhang F (2013) Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity. Cell 154:1380\u20131389","journal-title":"Cell"},{"key":"9856_CR62","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/nature14299","volume":"520","author":"FA Ran","year":"2015","unstructured":"Ran FA, Cong L, Yan WX, Scott DA, Gootenberg JS, Kriz AJ, Zetsche B, Shalem O, Wu X, Makarova KS, Koonin EV, Sharp PA, Zhang F (2015) In vivo genome editing using Staphylococcus aureus Cas9. Nature 520:186\u2013191","journal-title":"Nature"},{"key":"9856_CR63","doi-asserted-by":"crossref","first-page":"13348","DOI":"10.1038\/ncomms13348","volume":"7","author":"LS Reinert","year":"2016","unstructured":"Reinert LS, Lopu\u0161n\u00e1 K, Winther H, Sun C, Thomsen MK, Nandakumar R, Mogensen TH, Meyer M, V\u00e6gter C, Nyengaard JR, Fitzgerald KA, Paludan SR (2016) Sensing of HSV-1 by the cGAS-STING pathway in microglia orchestrates antiviral defence in the CNS. Nat Commun 7:13348","journal-title":"Nat Commun"},{"key":"9856_CR64","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nri3622","volume":"14","author":"PD Robbins","year":"2014","unstructured":"Robbins PD, Morelli AE (2014) Regulation of immune responses by extracellular vesicles. Nat Rev Immunol 14:195\u2013208","journal-title":"Nat Rev Immunol"},{"key":"9856_CR65","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/JVI.01863-09","volume":"84","author":"G Schnell","year":"2010","unstructured":"Schnell G, Price RW, Swanstrom R, Spudich S (2010) Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 84:2395\u20132407","journal-title":"J Virol"},{"key":"9856_CR66","doi-asserted-by":"crossref","first-page":"10437","DOI":"10.1073\/pnas.1512503112","volume":"112","author":"K Schumann","year":"2015","unstructured":"Schumann K, Lin S, Boyer E, Simeonov DR, Subramaniam M, Gate RE, Haliburton GE, Ye CJ, Bluestone JA, Doudna JA, Marson A (2015) Generation of knock-in primary human T cells using Cas9 ribonucleoproteins. Proc Natl Acad Sci U S A 112:10437\u201310442","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9856_CR67","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F (2014) Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343:84\u201387","journal-title":"Science"},{"key":"9856_CR68","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1089\/hum.2017.227","volume":"29","author":"S Shen","year":"2018","unstructured":"Shen S, Sanchez ME, Blomenkamp K, Corcoran EM, Marco E, Yudkoff CJ, Jiang H, Teckman JH, Bumcrot D, Albright CF (2018) Amelioration of Alpha-1 antitrypsin deficiency diseases with genome editing in transgenic mice. Hum Gene Ther 29:861\u2013873","journal-title":"Hum Gene Ther"},{"key":"9856_CR69","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1038\/ncb1800","volume":"10","author":"J Skog","year":"2008","unstructured":"Skog J, W\u00fcrdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10:1470\u20131476","journal-title":"Nat Cell Biol"},{"key":"9856_CR70","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1021\/acs.bioconjchem.8b00084","volume":"29","author":"CJ Slagle","year":"2018","unstructured":"Slagle CJ, Thamm DH, Randall EK, Borden MA (2018) Click conjugation of cloaked peptide ligands to microbubbles. Bioconjug Chem 29:1534\u20131543","journal-title":"Bioconjug Chem"},{"key":"9856_CR71","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.7150\/thno.26869","volume":"8","author":"KH Song","year":"2018","unstructured":"Song KH, Harvey BK, Borden MA (2018) State-of-the-art of microbubble-assisted blood-brain barrier disruption. Theranostics 8:4393\u20134408","journal-title":"Theranostics"},{"key":"9856_CR72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nbt.3806","volume":"35","author":"BT Staahl","year":"2017","unstructured":"Staahl BT, Benekareddy M, Coulon-Bainier C, Banfal AA, Floor SN, Sabo JK, Urnes C, Munares GA, Ghosh A, Doudna JA (2017) Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat Biotechnol 35:431\u2013434","journal-title":"Nat Biotechnol"},{"key":"9856_CR73","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41467-018-07971-8","volume":"10","author":"J Sun","year":"2019","unstructured":"Sun J, Carlson-Stevermer J, Das U, Shen M, Delenclos M, Snead AM, Koo SY, Wang L, Qiao D, Loi J, Petersen AJ, Stockton M, Bhattacharyya A, Jones MV, Zhao X, McLean PJ, Sproul AA, Saha K, Roy S (2019) CRISPR\/Cas9 editing of APP C-terminus attenuates \u03b2-cleavage and promotes \u03b1-cleavage. Nat Commun 10:53","journal-title":"Nat Commun"},{"key":"9856_CR74","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nbt.3055","volume":"33","author":"L Swiech","year":"2015","unstructured":"Swiech L, Heidenreich M, Banerjee A, Habib N, Li Y, Trombetta J, Sur M, Zhang F (2015) In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas9. Nat Biotechnol 33:102\u2013106","journal-title":"Nat Biotechnol"},{"key":"9856_CR75","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/s41598-017-18826-5","volume":"8","author":"M Teixeira","year":"2018","unstructured":"Teixeira M, Py BF, Bosc C, Laubreton D, Moutin MJ, Marvel J, Flamant F, Markossian S (2018) Electroporation of mice zygotes with dual guide RNA\/Cas9 complexes for simple and efficient cloning-free genome editing. Sci Rep 8:474","journal-title":"Sci Rep"},{"key":"9856_CR76","doi-asserted-by":"crossref","first-page":"42081","DOI":"10.1038\/srep42081","volume":"7","author":"Z Tu","year":"2017","unstructured":"Tu Z, Yang W, Yan S, Yin A, Gao J, Liu X, Zheng Y, Zheng J, Li Z, Yang S, Li S, Guo X, Li XJ (2017) Promoting Cas9 degradation reduces mosaic mutations in non-human primate embryos. Sci Rep 7:42081","journal-title":"Sci Rep"},{"key":"9856_CR77","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel G, D'Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19:213\u2013228","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9856_CR78","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMra1507771","volume":"374","author":"ND Volkow","year":"2016","unstructured":"Volkow ND, McLellan AT (2016) Opioid abuse in chronic pain--misconceptions and mitigation strategies. N Engl J Med 374:1253\u20131263","journal-title":"N Engl J Med"},{"key":"9856_CR79","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","volume":"153","author":"H Wang","year":"2013","unstructured":"Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R (2013) One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering. Cell 153:910\u2013918","journal-title":"Cell"},{"key":"9856_CR80","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.1246981","volume":"343","author":"T Wang","year":"2014","unstructured":"Wang T, Wei JJ, Sabatini DM, Lander ES (2014) Genetic screens in human cells using the CRISPR-Cas9 system. Science 343:80\u201384","journal-title":"Science"},{"key":"9856_CR81","doi-asserted-by":"crossref","first-page":"e0136046","DOI":"10.1371\/journal.pone.0136046","volume":"10","author":"HS Wollebo","year":"2015","unstructured":"Wollebo HS, Bellizzi A, Kaminski R, Hu W, White MK, Khalili K (2015) CRISPR\/Cas9 system as an agent for eliminating polyomavirus JC infection. PLoS One 10:e0136046","journal-title":"PLoS One"},{"key":"9856_CR82","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jim.2018.03.009","volume":"457","author":"CM Wu","year":"2018","unstructured":"Wu CM, Roth TL, Baglaenko Y, Ferri DM, Brauer P, Zuniga-Pflucker JC, Rosbe KW, Wither JE, Marson A, Allen CDC (2018) Genetic engineering in primary human B cells with CRISPR-Cas9 ribonucleoproteins. J Immunol Methods 457:33\u201340","journal-title":"J Immunol Methods"},{"key":"9856_CR83","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1038\/s41467-018-07566-3","volume":"9","author":"H Yamaguchi","year":"2018","unstructured":"Yamaguchi H, Hopf FW, Li SB, de Lecea L (2018) In vivo cell type-specific CRISPR knockdown of dopamine beta hydroxylase reduces locus coeruleus evoked wakefulness. Nat Commun 9:5211","journal-title":"Nat Commun"},{"key":"9856_CR84","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.celrep.2018.11.019","volume":"25","author":"S Yang","year":"2018","unstructured":"Yang S, Li S, Li XJ (2018) Shortening the half-life of Cas9 maintains its gene editing ability and reduces neuronal toxicity. Cell Rep 25:2653\u20132659.e3","journal-title":"Cell Rep"},{"key":"9856_CR85","doi-asserted-by":"crossref","unstructured":"Zallar LJ, Tunstall BJ, Richie CT, Zhang YJ, You ZB, Gardner EL, Heilig M, Pickel J, Koob GF, Vendruscolo LF, Harvey BK, Leggio L (2018) Development and initial characterization of a novel ghrelin receptor CRISPR\/Cas9 knockout wistar rat model. Int J Obes","DOI":"10.1038\/s41366-018-0013-5"},{"key":"9856_CR86","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff M (2002) Antimicrobial peptides of multicellular organisms. Nature 415:389\u2013395","journal-title":"Nature"},{"key":"9856_CR87","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.4081\/idr.2013.s1.e8","volume":"5","author":"L Zhou","year":"2013","unstructured":"Zhou L, Saksena NK (2013) HIV associated neurocognitive disorders. Infect Dis Rep 5:e8","journal-title":"Infect Dis Rep"}],"container-title":["Journal of Neuroimmune Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11481-019-09856-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11481-019-09856-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:24:31Z","timestamp":1591313071000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11481-019-09856-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":87,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["9856"],"URL":"https:\/\/doi.org\/10.1007\/s11481-019-09856-z","relation":{},"ISSN":["1557-1890","1557-1904"],"issn-type":[{"type":"print","value":"1557-1890"},{"type":"electronic","value":"1557-1904"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"14 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal studies were carried out following the Guide for the Care and Use of Laboratory Animals as adopted and promulgated by the U.S. National Institutes of Health and approved by the National Institute on Drug Abuse IRP internal review board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal Studies"}}]}}